ArticleDrugs2022

Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19.

John G Rizk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.